Inspection Record

Diversified Pharmacy Inc dba University Compounding Pharmacy — FDA 483 Findings

US FDAInspected 2016-10-20Published 2024-01-17 8 findingsQuality unit oversightAseptic processing and sterility assuranceContamination controlStability and storageEquipment and facility

Inspectors Sarah M. Napier · Emily J. OrbanThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Quality unit oversight

The responsibilities and procedures applicable to the quality control unit are not in writing.

2Aseptic processing and sterility assurance

Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to determine conformance to such requirements.

3Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding systems for maintaining any equipment used to control the aseptic conditions.

4Aseptic processing and sterility assurance

Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.

5Aseptic processing and sterility assurance

Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established.

6Contamination control

Container closure systems do not provide adequate protection against foreseeable external factors in storage and use that can cause deterioration or contamination of the drug product .

7Stability and storage

There is no written testing program designed to assess the stability characteristics of drug products.

8Equipment and facility

The operations relating to the processing ofpenicillin are not performed in facilities separate from those used for other drug products for human use.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Diversified Pharmacy Inc dba University Compounding Pharmacy company profile — full history US FDA documents, 2024 Go to Findings search